Publications:248
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Richard G Stock, MD
Radiation Oncology
About Me
Dr. Richard Stock has dedicated his career to delivering the highest quality care to patients using the most advanced technology available, including intensity modulated radiation therapy (IMRT), Novalis shaped beam radiosurgery, real-time ultrasound guided prostate seed implants and Mammosite, all of which allows for meticulously targeting the tumor while achieving maximal sparing of normal tissues.
Dr. Stock has served on the board of American College of Radiology Testing and the American Brachytherapy Society, where he is member at large, and as guest editor of a special Brachytherapy issue of Techniques in Urology. He has lectured and presented at dozens of meetings and symposiums across the country and internationally, including New York, San Francisco, Chicago, Philadelphia, Boston, Spain, Holland, France and Japan.
Dr. Stock completed his internship at Beth Israel Medical Center and his specialty training at Memorial Sloan-Kettering Cancer Center. He is listed in America's Top Doctors.
In the News
Dr. Stock discusses prostate cancer in The Daily News feature The Daily Check Up.
View the PDF.
Read the commentary by Richard G. Stock, MD, Simon J. Hall, MD, William K.Oh, MD, and David B. Samadi, MD, "Fighting Round Two: Recurrent Prostate Cancer" that appeared in the New York Times on June 8, 2010. View the PDF.
{C}
Language
English
Position
PROFESSOR | Radiation Oncology
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Bladder Cancer
- Bone Cancer
- Prostate Cancer
- Testicular Cancer
Education
MD, Icahn School of Medicine at Mount Sinai
Internship, Internal Medicine
Mount Sinai Beth Israel
Residency, Internal Medicine
Beth Israel Medical Center-Petrie Division
Residency, Radiation Oncology
Memorial Sloan-Kettering Cancer Center
Residency, Radiation Oncology
Memorial Sloan-Kettering Cancer Center
Certifications
Radiation Oncology
Research
Dr. Stock's specific focus is prostate cancer and prostate brachytherapy. He established a comprehensive prostate cancer database with a corresponding IRB approved protocol to track treatment outcomes following prostate cancer therapies. This has enabled him to obtain important medical information on the growing field of low dose rate brachytherapy and prostate cancer. Dr. Stock's efforts over the past 16 years, which includes 145 peer reviewed and invited papers, and book chapters, have contributed much to our understanding of prostate brachytherapy. He has helped set standards for dosing issues and implant quality. In addition, he has collaborated with other brachytherapy centers to publish multi-institutional series which have further enhanced our understanding of this treatment modality. Working in collaboration with other researchers, Dr. Stock has studied the relationship between genetic mutations and radiation side effects in patients undergoing radiation for prostate cancer. He is a co-investigator on a Department of Defense, American Cancer Society, and NIH RO1 grants to study this new and exciting area of research. In a recent publication in the International Journal of Radiation Oncology Biology Physics, Dr. Stock ranked among the top 4% of academic radiation oncologists in terms of the h-factor, a surrogate score for research productivity.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- 32BJ Health Fund
- AETNA - Commercial
- AETNA - Medicare
- Amidacare Medicaid
- Anthem/Empire Blue Cross Blue Shield - Commercial
- Anthem/Empire Blue Cross Blue Shield - HealthPlus Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients. Philipp Heumann, Miguel E. Aguado-Barrera, Harkeran K. Jandu, David Azria, Erik Briers, Renée Bultijnck, Jenny Chang-Claude, Ananya Choudhury, Alison M. Dunning, Laura Fachal, Olivia Fuentes-Ríos, Antonio Gómez-Caamaño, Sara Gutiérrez-Enríquez, Rudolf Kaaks, Sarah L. Kerns, Maarten Lambrecht, Juan Camilo Rosas Romero, Barry S. Rosenstein, Dirk De Ruysscher, Martina E. Schmidt, Elena Sperk, Hilary Stobart, R. Paul Symonds, Liv Veldeman, Marlon R. Veldwijk, Tim Ward, Adam Webb, Catharine M.L. West, Tiziana Rancati, Tim Rattay, Ana Vega, Subramaniam Vasanthan, Ben Vanneste, Riccardo Valdagni, Laura Torrado-Moya, Begoña Taboada-Valladares, Holly Summersgill, Richard Stock, Petra Stegmaier, Paloma Sosa-Fajardo, Rebecca M. Shearer, Belinda Rodriguez-Lage, Paula Peleteiro, Debbie Payne, Piet Ost, Sara Morlino, Ramón Lobato-Busto, Christopher Kent, Kiran Kancherla, Carsten Herskind. Nature Communications
- Dosimetric Predictors of Problematic Receptive Anal Intercourse After Prostate Radiation Therapy. Daniel R. Dickstein, Thodori Kapouranis, Andre Williams, Victoria Olsen, Kathryn E. Flynn, Robert Stewart, Barry S. Rosenstein, Tian Liu, Richard Stock, Rendi Sheu, Michael Lovelock, Andrew Jackson, Karyn A. Goodman, Deborah C. Marshall. Advances in Radiation Oncology
- Sexual Health Outcomes in Sexual Minority and Heterosexual Men After Prostate Radiation Therapy. Daniel R. Dickstein, Thodori Kapouranis, Keith Sigel, Christopher W. Wheldon, Eva Nvepu, Noelle Marie Javier, Robert Stewart, Matthew Galsky, John Sfakianos, Joshua D. Safer, Richard Stock, Karyn Goodman, B. R.Simon Rosser, Kathryn E. Flynn, Deborah C. Marshall. International Journal of Radiation Oncology Biology Physics
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.8 out of 5
Care Provider’s Concern
4.8 out of 5
Likelihood to Recommend Care Provider
4.7 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Stock has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.